Back to search results

Support Program for Chinese Cancer Patients and Survivors

This study is testing different combinations of support programs for Chinese cancer patients and survivors. These programs include Cancer Education (information on side effects, treatment, and survivorship), Meaning-Centered Counseling (to help with coping strategies), and Peer Support (group meetings to reduce stigma). Researchers want to see if these combinations are practical and effective, and how they improve your quality of life. You may be able to join if you are at least 18 years old, of Chinese descent, speak Mandarin well, have been diagnosed with cancer in the last 5 years, and live in New York or a nearby area. The study aims to enroll 64 participants and will measure how many eligible people join and how many complete the program.

Study design
This is an interventional study with a planned enrollment of 64 participants. It is not specified if it is randomized or blinded.
What's involved
You would participate in sessions for Cancer Education (30-60 minutes), Meaning-Centered Counseling (45-60 minutes), and Peer Support meetings, all conducted over the phone or by video call. The study will measure completion of treatment at 24 weeks.
Compensation
Not stated in the trial record.
Follow-up
The study will track participants for 2 years to see how many enroll, and for 24 weeks to see how many complete treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07454330

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

Recruiting
NAAges 18+InterventionalSupportive care
Memorial Sloan Kettering Cancer Center
~64 participants
Updated 2026-08-13 on ClinicalTrials.gov
What's tested:Cancer EducationMeaning-Centered CounselingPeer SupportEnhanced Standard Care

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of eligible participants who enroll in the trial.
Measured over 2 years
+1 more outcome measured

Conditions

Cancer
Survivorship

Explore related trials

Malignant Neoplasm

Where it's being run

7 sites across 2 states
New York4
New Jersey3

Study leadership

  • Florence Lui, PhD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Florence Lui, PhD
[email protected]
646-888-8375
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years
Age ≥ 18 years (per EMR for MSK patients or self-report for external participants)
Of Chinese descent
Speaks Mandarin "well" or "very well"
Moderately low HRQOL (\<70 FACT-G score)4, 48
Resides in New York or New Jersey
Agrees to participate via telehealth (video or phone)
Agrees to be audio-recorded

Exclusion

Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of \> 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS)
Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?"
Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score \< 12)
Per consenting professional determination, unable to understand the informed consent procedure
Participation in study #14-076: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese immigrant cancer patients)
Currently receiving/have received psychotherapy/counseling/peer support within the last 6 months (patients being treated solely with psychotropic medications will not be excluded if they are not receiving psychotherapy/counseling/peer support)

What this trial measures

  • Proportion of eligible participants who enroll in the trial.2 years
  • Proportion of participants who complete treatment24 weeks

    Pproportion of assessments that are completed, with completion defined as submitting the 24-week assessment with a minimum of the FACT-G completed.